The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients with Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial

Angela M. Reiersen, Caline Mattar, Rachel A. Bender Ignacio, David R. Boulware, Todd C. Lee, Rachel Hess, Alexander J. Lankowski, Emily G. McDonald, J. Philip Miller, William G. Powderly, Matthew F. Pullen, Jeffrey T. Rado, Michael W. Rich, Joshua T. Schiffer, Julie Schweiger, Adam M. Spivak, Angela Stevens, Simone N. Vigod, Payal Agarwal, Lei YangMichael Yingling, Torie R. Gettinger, Charles F. Zorumski, Eric J. Lenze

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'The STOP COVID 2 Study: Fluvoxamine vs Placebo for Outpatients with Symptomatic COVID-19, a Fully Remote Randomized Controlled Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences